2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

O'Gara, Patrick T., Kushner, Frederick G., Ascheim, Deborah D., Casey, Donald E., Chung, Mina K., de Lemos, James A., Ettinger, Steven M., Fang, James C. +15 more·2013·Journal of the American College of Cardiology

Cited by (1,001)

Items 301–400 of 1,001

  1. Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home ( H 2 H ) Initiative
    Barbara S. Wiggins, Jo E. Rodgers, Robert J. DiDomenico, Abigail M. Cook, Robert Lee Page II · 2013 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  2. 4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
    Eva Caroff, Francis Hubler, Emmanuel A. Meyer, Dorte Renneberg, Carmela Gnerre, Alexander Treiber, Markus Rey, Patrick Hess, Beat Steiner, Kurt Hilpert et al. · 2015 · Journal of Medicinal Chemistry
  3. Performance of Emergency Department Screening Criteria for an Early ECG to Identify ST‐Segment Elevation Myocardial Infarction
    Maame Yaa A. B. Yiadom, Christopher W. Baugh, Conor M. McWade, Xulei Liu, Kyoung Jun Song, Brian W. Patterson, Cathy A. Jenkins, Mary Tanski, Angela M. Mills, Gilberto Salazar et al. · 2017 · Journal of the American Heart Association
  4. Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction
    Raquel P. Amier, Martijn W. Smulders, Wiesje M. van der Flier, Sebastiaan C.A.M. Bekkers, Alwin Zweerink, Cornelis P. Allaart, Ahmet Demirkıran, Sebastiaan T. Roos, Paul F. A. Teunissen, Yolande Appelman et al. · 2018 · JACC. Cardiovascular imaging
  5. Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarction
    Aloysius Sheng‐Ting Leow, Ching‐Hui Sia, Benjamin Yong‐Qiang Tan, Rajinderdeep Kaur, Tiong‐Cheng Yeo, Mark Y. Chan, Edgar Lik‐Wui Tay, Raymond C.S. Seet, Joshua Ping-Yun Loh, Leonard L.L. Yeo · 2019 · Journal of Thrombosis and Thrombolysis
  6. Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction
    Zhongfan Zhang, Daoyuan Si, Qian Zhang, Lina Jin, Haikuo Zheng, Ming Fei Qu, Miao Yu, Zhenya Jiang, Delin Li, Souping Li et al. · 2022 · JACC: Cardiovascular Interventions
  7. All-Trans Retinoic Acid Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Cardiomyocyte Apoptosis
    Zhengbin Zhu, Jinzhou Zhu, Xiaoran Zhao, Ke Yang, Lin Lu, Fengru Zhang, Weifeng Shen, Ruiyan Zhang · 2015 · PLoS ONE
  8. Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial
    Matthijs A. Velders, Lars C. Wallentin, Richard Clinton Becker, Adrianus Johannes van Boven, Anders Himmelmänn, Steen Husted, Hugo Albert Katus, Daniel P. Lindholm, João Morais, Agneta G Siegbahn et al. · 2015 · American Heart Journal
  9. New Approaches to Inhibiting Platelets and Coagulation
    Jeremiah Peter Depta, Deepak L. Bhatt · 2015 · The Annual Review of Pharmacology and Toxicology
  10. Therapeutic hypothermia in ST elevation myocardial infarction: a systematic review and meta-analysis of randomised control trials
    Pedro Arturo Villablanca, Gaurav Rao, David Felipe Briceno, Marissa Lombardo, Harish Ramakrishna, Anna E. Bortnick, Mario Jorge Garcia, Mark A. Menegus, Daniel B. Sims, Mohammed Makkiya et al. · 2016 · Heart
  11. Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial Infarction
    Marc Mourad, Philippe Gaudard, Pablo De la Arena, Jacob Eliet, Norddine Zeroual, Philippe Rouvière, François Roubille, Bernard Albat, Pascal H. Colson · 2017 · ASAIO Journal
  12. The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure
    Jin Joo Park, Sun–Hwa Kim, Il‐Young Oh, Dong‐Ju Choi, Hyun Ah Park, Hyun‐Jai Cho, Hae‐Young Lee, Jae-Yeong Cho, Kye Hun Kim, Jung‐Woo Son et al. · 2018 · JACC Heart Failure
  13. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
    John Munkhaugen, Vidar de Bourg Ruddox, Sigrun Halvorsen, Toril Dammen, Morten Wang Fagerland, Kjersti Helene Hernæs, Nils Tore Vethe, Eva Prescott, Svend Eggert Jensen, Olaf Rødevand et al. · 2018 · American Heart Journal
  14. Predictors of cardiac rehabilitation referral, enrolment and completion after acute myocardial infarction: an exploratory study
    R W M Brouwers, V Houben, Jos Johannes Kraal, Ruud F. Spee, Hareld Kemps · 2020 · Netherlands Heart Journal
  15. Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset
    Steffen Desch, Thomas Stiermaier, Suzanne de Waha, Philipp C. Lurz, Matthias Gutberlet, Marcus Sandri, Norman Mangner, Enno Boudriot, Michael Woinke, Sandra Erbs et al. · 2016 · JACC: Cardiovascular Interventions
  16. Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists*
    Kenneth E. Remy, Philip A. Verhoef, Jay R. Malone, Michael D. Ruppe, Timothy B. Kaselitz, Frank Lodeserto, Eliotte L. Hirshberg, Anthony D. Slonim, Cameron Dezfulian · 2020 · Pediatric Critical Care Medicine
  17. Anti‐Inflammatory Effect of Curcumin on the Mouse Model of Myocardial Infarction through Regulating Macrophage Polarization
    Shaoxi Yan, Mo Zhou, Xiaoyun Zheng, Yuanyuan Xing, Juan Dong, Mengwen Yan, Rui Li · 2021 · Mediators of Inflammation
  18. Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study
    Daniel Mølager Christensen, Anne-Marie Schjerning, Lærke Smedegaard, Mette Gitz Charlot, Pauline B. Ravn, Anne‐Christine Ruwald, Emil Loldrup Fosbøl, Lars Køber, Christian Tobias Torp-Pedersen, Morten Schou et al. · 2022 · European Heart Journal
  19. The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement
    Andreas Kumar, Kim Alexander Connelly, Keyur P. Vora, Kevin R. Bainey, Andrew G. Howarth, Jonathon A. Leipsic, Suzanne Betteridge-LeBlanc, Frank S. Prato, Howard M. Leong-Poi, Anthony Main et al. · 2023 · Canadian Journal of Cardiology
  20. An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention
    Rahman Shah, Kelly C. Rogers, Khalid Matin, Raza Askari, Sunil V. Rao · 2015 · American Heart Journal
  21. Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y 12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study
    Jamal Nasir Khan, John Pierre Greenwood, Sheraz A. Nazir, Florence Y. Lai, Miles C. D. Dalby, Nick P. Curzen, Simon Lee Hetherington, Damian J. Kelly, Daniel J. Blackman, Charles Peebles et al. · 2016 · Journal of the American Heart Association
  22. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention
    Apurva A. Motivala, Valay K. Parikh, Matthew T. Roe, David Dai, Jinnette Dawn Abbott, Abhiram Prasad, Debabrata Mukherjee · 2016 · JACC: Cardiovascular Interventions
  23. Interhospital Transfer of Patients With Acute Pulmonary Embolism
    Parth M. Rali, Daniel C. Sacher, Belinda N. Rivera‐Lebron, Rachel Pam Greenerger Rosovsky, Jean Elwing, Jonathan Berkowitz, Bushra A. Mina, Bhavin Dalal, George A. Davis, David Michael Dudzinski et al. · 2021 · CHEST Journal
  24. Where Are We With Treatment and Prevention of Heart Failure in Patients Post–Myocardial Infarction?
    Jaclyn Carberry, Guillaume Marquis‐Gravel, Eileen O’Meara, Kieran F. Docherty · 2024 · JACC Heart Failure
  25. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention
    Yacov Shacham, Eran Leshem‐Rubinow, Arie Steinvil, Gad Keren, Arie Roth, Yaron Arbel · 2014 · Clinical and Experimental Nephrology
  26. Peak and Fixed-Time High-Sensitive Troponin for Prediction of Infarct Size, Impaired Left Ventricular Function, and Adverse Outcomes in Patients With First ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
    Helèn Boden, Tarek Abdel-Hameed Nagib Ahmed, Matthijs A. Velders, Bas L. van der Hoeven, Georgette E. Hoogslag, Marianne Bootsma, Saskia le Cessie, Christa M. Cobbaert, Victoria Delgado, Arnoud van der Laarse et al. · 2013 · The American Journal of Cardiology
  27. Evidence-Based Cardiology in Hemodialysis Patients
    Michael Allon · 2013 · Journal of the American Society of Nephrology
  28. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies
    Vasken Dilsizian, Henry Gewirtz, Nicholas Paivanas, Anastasia N. Kitsiou, Fadi G. Hage, Nathan E. Crone, Ronald G. Schwartz · 2015 · Journal of Nuclear Cardiology
  29. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction
    Doo Sun Sim, Myung Ho Jeong, Youngkeun Ahn, Young Jo Kim, Shung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, Chong Jin Kim, Myeong‐Chan Cho et al. · 2016 · Circulation Cardiovascular Interventions
  30. Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Nontarget Vascular Territories in a Porcine Microvascular Injury Model
    Joo Myung Lee, Hyun Kuk Kim, Kyung Seob Lim, Jun‐Kyu Park, Ki Hong Choi, Jonghanne Park, Doyeon Hwang, Tae‐Min Rhee, Jeong Hoon Yang, Eun‐Seok Shin et al. · 2018 · JACC: Cardiovascular Interventions
  31. Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China
    Yangfeng Wu, Shenshen Li, Anushka A Patel, Xian Li, Xin Du, Tao Wu, Yifei Zhao, Feng Lin, Laurent Billot, Eric David Peterson et al. · 2019 · JAMA Cardiology
  32. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold
    Jens Wiebe, Helge Möllmann, Astrid Kerstin Most, Oliver Dörr, Kay F. Weipert, Johannes Rixe, Christoph Liebetrau, Albrecht Elsässer, Stephan S. Achenbach, Christian W. Hamm et al. · 2013 · Clinical Research in Cardiology
  33. Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review
    Chen, Han-Yang, Saczynski, Jane S., Lapane, Kate L., Kiefe, Catarina I., Goldberg, Robert J. · 2015 · Heart & Lung
  34. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock
    Tyler C. Lewis, Caitlin Aberle, Diana Altshuler, Greta L. Piper, John Papadopoulos · 2018 · Journal of Cardiovascular Pharmacology and Therapeutics
  35. Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
    Kun‐Ling Tsai, Pei‐Ling Hsieh, Wan-Ching Chou, Hui-Ching Cheng, Yu‐Ting Huang, Shih‐Hung Chan · 2021 · Cell & Bioscience
  36. Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention
    Jacob Allen Udell, Eugene Braunwald M. D, Elliot M. Antman, Sabina A. Murphy, Gilles Montalescot, Stephen D. Wiviott · 2014 · JACC: Cardiovascular Interventions
  37. Prophylactic Warfarin Therapy After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction
    Michel R. Le May, Sudikshya Acharya, George A. Wells, Ian G. Burwash, Aun‐Yeong Chong, Derek Y F So, Chris A. Glover, Michael P.V. Froeschl, Benjamin M. Hibbert, Jean-François Marquis et al. · 2014 · JACC: Cardiovascular Interventions
  38. Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes
    David M. Safley, Lakshmi Venkitachalam, Kevin F. Kennedy, David J. Cohen · 2015 · JACC: Cardiovascular Interventions
  39. Current status of data on cangrelor
    Arman Qamar, Deepak L. Bhatt · 2016 · Pharmacology & Therapeutics
  40. Statins Reduce Lipopolysaccharide-Induced Cytokine and Inflammatory Mediator Release in an In Vitro Model of Microglial-Like Cells
    Amelia J. McFarland, Andrew Keith Davey, Shailendra Anoopkumar‐Dukie · 2017 · Mediators of Inflammation
  41. Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines
    Perry Wengrofsky, Justin Lee, Amgad N. Makaryus · 2019 · IntechOpen eBooks
  42. Temporal Trends and Outcomes of Left Ventricular Aneurysm After Acute Myocardial Infarction
    Saraschandra Vallabhajosyula, Siddak S. Kanwar, Htin Aung, Wisit Cheungpasitporn, Claire E. Raphael, Rajiv Gulati, Mandeep Singh · 2020 · The American Journal of Cardiology
  43. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes
    Gorav Batra, Johan Lindbäck, Richard Clinton Becker, Robert A. Harrington, Claes Held, Stefan Karl James, Tibor Kempf, Renato D. Lópes, Kenneth W. Mahaffey, Philippe Gabríel Steg et al. · 2022 · Journal of the American College of Cardiology
  44. Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention
    Uwe Zeymer, Hans‐Christian Mochmann, Bernd Mark, Hans-Richard Arntz, Hölger Thiele, Frank Diller, Gilles Montalescot, Ralf Zahn · 2014 · JACC: Cardiovascular Interventions
  45. Hypertensive Emergencies in the Emergency Department
    Omoyemi Adebayo, Robert L. Rogers · 2015 · Emergency Medicine Clinics of North America
  46. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention
    Kaiyang Lin, Wei-ping Zheng, Wei‐jie Bei, Shiqun Chen, Sheikh Mohammed Shariful Islam, Yong Liu, Xue Lin, Ning Tan, Jiyan Chen · 2016 · International Journal of Cardiology
  47. Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction
    Wanda Y. Wu, David W. Biery, Avinainder Singh, Sanjay Divakaran, Adam N. Berman, Gloria A. Ayuba, Ersilia M. DeFilippis, Khurram Nasir, James L. Januzzi, Marcelo F. Di Carli et al. · 2020 · Journal of the American College of Cardiology
  48. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease
    Varunsiri Atti, Yeongjin Gwon, Mahesh Anantha Narayanan, Santiago A. Garcia, Yader B. Sandoval, Emmanouil S. Brilakis, Mir B. Basir, Mohit K. Turagam, Akshay K. Khandelwal, Carlos Mena‐Hurtado et al. · 2020 · JACC: Cardiovascular Interventions
  49. The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry
    Jae‐Sik Jang, Kyoo‐Rok Han, Keon‐Woong Moon, Dong Woon Jeon, Dong‐Ho Shin, Jung‐Sun Kim, Duk‐Woo Park, Hyun‐Jae Kang, Ju Han Kim, Jang‐Whan Bae et al. · 2017 · Korean Circulation Journal
  50. Total Automation for the Core Laboratory: Improving the Turnaround Time Helps to Reduce the Volume of Ordered STAT Tests
    Ialongo, Cristiano, Porzio, Ottavia, Giambini, Ilio, Bernardini, Sergio · 2016 · SLAS Technology
  51. Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness
    Joshua Schulman‐Marcus, Parag Goyal, Rajesh V. Swaminathan, Dmitriy N. Feldman, Shing–Chiu Wong, Harsimran Sachdeva Singh, Robert M. Minutello, Geoffrey W. Bergman, Luke K. Kim · 2016 · The American Journal of Cardiology
  52. Optimal P2Y 12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Asim M. Rafique, Piyush Nayyar, Tracy Y. Wang, Roxana Mehran, Usman Baber, Peter B. Berger, Jonathan M. Tobis, Jesse W. Currier, Ravi H. Dave, Timothy D. Henry · 2016 · JACC: Cardiovascular Interventions
  53. Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI
    Benedetta Bellandi, Chiara Zocchi, Ioanna Xanthopoulou, Fernando Scudiero, Renato Valenti, Angela Migliorini, David Antoniucci, Niccolò Marchionni, Dimitrios Alexopoulos, Guido Parodi · 2016 · International Journal of Cardiology
  54. Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to action
    RICHARD J. KONES, Umme Rumana · 2016 · Annals of Medicine
  55. Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction
    Jamal Nasir Khan, Gerry Patrick McCann · 2017 · World Journal of Cardiology
  56. Ten‐Year (2001–2011) Trends in the Incidence Rates and Short‐Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction
    Hoa Lan Nguyen, Jorge Yarzebski, Darleen Lessard, Joel M. Gore, David D. McManus, Robert Joel Goldberg · 2017 · Journal of the American Heart Association
  57. Contemporary prevalence, trends, and outcomes of coronary chronic total occlusions in acute myocardial infarction with cardiogenic shock
    Saraschandra Vallabhajosyula, Abhiram Prasad, Rajiv Gulati, Gregory W. Barsness · 2019 · IJC Heart & Vasculature
  58. Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock.
    Zaid I. Almarzooq, Yang Song, I. Dahabreh, Ajar Kochar, E. Ferro, E. Secemsky, J. Major, A. Farb, Changfu Wu, Bram D. Zuckerman et al. · 2023 · JAMA cardiology
  59. Regional Density of Cardiologists and Rates of Mortality for Acute Myocardial Infarction and Heart Failure
    Vivek Kulkarni, Joseph S. Ross, Yongfei Wang, Brahmajee K. Nallamothu, John A. Spertus, Sharon‐Lise T. Normand, Frederick A. Masoudi, Harlan M. Krumholz · 2013 · Circulation Cardiovascular Quality and Outcomes
  60. World Heart Federation Expert Consensus Statement on Antiplatelet Therapy in East Asian Patients with ACS or Undergoing PCI
    Glenn N. Levine, Young‐Hoon Jeong, Shinya Goto, Jeffrey L. Anderson, Yong Huo, Jessica L. Mega, Kathryn A. Taubert, Sidney C. Smith · 2014 · Global Heart
  61. Optimal revascularization for complex coronary artery disease
    Javaid Iqbal, Patrick W.J.C. Serruys, David Paul Taggart · 2013 · Nature Reviews Cardiology
  62. Top 10 cardiovascular therapies and interventions for the next decade
    Valentı́n Fuster · 2014 · Nature Reviews Cardiology
  63. Meta-Analysis of the Impact on Mortality of Noninfarct-Related Artery Coronary Chronic Total Occlusion in Patients Presenting With ST-Segment Elevation Myocardial Infarction
    Stephen A. O’Connor, Philippe Garot, Francesca Sanguineti, Loes P. C. Hoebers, Thierry Unterseeh, Hakim Benamer, Bernard Chevalier, Thomas Hovasse, Marie‐Claude Morice, Thierry Lefèvre et al. · 2015 · The American Journal of Cardiology
  64. Quantitative Dobutamine Stress Echocardiography Using Speckle-Tracking Analysis versus Conventional Visual Analysis for Detection of Significant Coronary Artery Disease after ST-Segment Elevation Myocardial Infarction
    Emer Joyce, Georgette E. Hoogslag, Ibthial Al Amri, Philippe Debonnaire, Spyridon Katsanos, Jeroen Joost Bax, Victoria Delgado, Nina Ajmone Marsan · 2015 · Journal of the American Society of Echocardiography
  65. Comparison of Outcomes of Women Versus Men With Non–ST-elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the Japanese Nationwide Registry)
    Yohei Numasawa, Taku Inohara, Hideki Ishii, Toshiki Kuno, Masaki Kodaira, Shun Kohsaka, Kenshi Fujii, Shiro Uemura, Tetsuya Amano, Kazushige Kadota et al. · 2016 · The American Journal of Cardiology
  66. Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality
    Patrick W. McNair, Kenneth C. Bilchick, Ellen C. Keeley · 2019 · IJC Heart & Vasculature
  67. Diagnosis of acute myocardial infarction in the presence of left bundle branch block
    Thomas Nestelberger, Louise Cullen, Bertil Lindahl, Tobias Reichlin, Jaimi H. Greenslade, Evangelos Giannitsis, Michael Christ, Beata Morawiec, Òscar Miró, Francisco Javier Martín‐Sánchez et al. · 2019 · Heart
  68. Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock
    Alejandro Lemor, Mir B. Basir, Kirit Patel, Brian C. Kolski, Amir Kaki, Navin Kumar Kapur, Robert Riley, John Finley, Andrew Michael Goldsweig, Herbert D. Aronow et al. · 2020 · JACC: Cardiovascular Interventions
  69. Advancements in Percutaneous Coronary Intervention Techniques: A Comprehensive Literature Review of Mixed Studies and Practice Guidelines
    Muhammad Abubakar, Izzah Javed, Hafiz Fahad Rasool, Saud Raza, Deepak Basavaraju, Rai Muhammad Abdullah, Faizan Ahmed, Siffat Saima Salim, Muhammad Ahmad Faraz, Khawaja Mushammar Hassan et al. · 2023 · Cureus
  70. Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
    Yacov Shacham, Amir Gal‐Oz, Eran Leshem‐Rubinow, Yaron Arbel, Gad Keren, Arie Roth, Arie Steinvil · 2015 · Cardiorenal Medicine
  71. Cardioprotection in ischaemia–reperfusion injury: novel mechanisms and clinical translation
    Francisco J Altamirano, Zhao V. Wang, Joseph A. Hill · 2015 · The Journal of Physiology
  72. Neutrophil count improves the GRACE risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction
    Sumei Zhang, Zhaofei Wan, Yongai Zhang, Yan Fan, Wei Gu, Fei Li, Li Meng, Xiaoyan Zeng, Dongfang Han, Xiaomei Li · 2015 · Atherosclerosis
  73. Drug-eluting stents versus bare-metal stents for acute coronary syndrome
    Joshua Buron Feinberg, Emil Eik Nielsen, Janette Greenhalgh, Juliet C. Hounsome, Naqash J Sethi, Sanam Safi, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2017 · Cochrane Database of Systematic Reviews
  74. Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel
    Wen Hu, Jin Tong, Xue Kuang, Weijie Chen, Zengzhang Liu · 2018 · Medicine
  75. The de winter electrocardiogram pattern is a transient electrocardiographic phenomenon that presents at the early stage of ST‐segment elevation myocardial infarction
    Jing Xu, Aihua Wang, Li Liu, Zijun Chen · 2018 · Clinical Cardiology
  76. Twenty-five year trends (1986-2011) in hospital incidence and case-fatality rates of ventricular tachycardia and ventricular fibrillation complicating acute myocardial infarction
    Hoang V. Tran, Arlene S. Ash, Joel M. Gore, Chad E. Darling, Catarina I. Kiefe, Robert Joel Goldberg · 2018 · American Heart Journal
  77. High-loading Gα 13 -binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injury
    Aiming Pang, Ni Cheng, Yujie Cui, Yanyan Bai, Zhigang Hong, Michael Keegan Delaney, Yaping Zhang, Claire Wei-Ju Chang, Can Wang, Chang Liu et al. · 2020 · Science Translational Medicine
  78. The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine
    A. Esposito, G. Gallone, A. Palmisano, L. Marchitelli, F. Catapano, M. Francone · 2020 · La radiologia medica
  79. STEMI: A transitional fossil in MI classification?
    Emre K. Aslanger, Harvey Pendell Meyers, Stephen W. Smith · 2021 · Journal of Electrocardiology
  80. Sex differences in acute cardiovascular care: a review and needs assessment
    Saraschandra Vallabhajosyula, Dhiran Verghese, Viral K. Desai, Pranathi Rao Sundaragiri, Virginia M. Miller · 2021 · Cardiovascular Research
  81. 10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population
    Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Troels Thim, Christine Gyldenkerne, Malene Kærslund Hansen, Nina Stødkilde-Jørgensen, Lars Jakobsen, Martin Bødtker Mortensen, Steen Dalby Kristensen, Michael Mæng · 2024 · Journal of the American College of Cardiology
  82. Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention
    Yacov Shacham, Eran Leshem‐Rubinow, Amir Gal‐Oz, Yaron Arbel, Gad Keren, Arie Roth, Arie Steinvil · 2015 · Canadian Journal of Cardiology
  83. Impact of Red Blood Cell Distribution Width on Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction
    Xipeng Sun, Wen-Ming Chen, Zhi-jun Sun, Xiaosong Ding, Xiangyu Gao, Siwen Liang, Zhao Hui-qiang, Dao-Kuo Yao, Hui Chen, Hongwei Li et al. · 2014 · Cardiology
  84. The Role of the Wearable Cardioverter Defibrillator in Clinical Practice
    Mina K. Chung · 2014 · Cardiology Clinics
  85. A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study
    Derek Y F So, George A. Wells, Ruth McPherson, Marino X. Labinaz, Michel R. Le May, Christopher A. Glover, ALEXANDER J. DICK, Michael P.V. Froeschl, J. Marquis, Michael H. Gollob et al. · 2015 · The Pharmacogenomics Journal
  86. Effect of Impella During Veno-Arterial Extracorporeal Membrane Oxygenation on Pulmonary Artery Flow as Assessed by End-Tidal Carbon Dioxide
    Jacob Eliet, Philippe Gaudard, Norddine Zeroual, Philippe Rouvière, Bernard Albat, Marc Mourad, Pascal H. Colson · 2017 · ASAIO Journal
  87. Progress Toward Improved Cardiovascular Health in the United States
    Katherine Pahigiannis, Angela M. Thompson‐Paul, Whitney L. Barfield, Emmeline Ochiai, Fleetwood V Loustalot, Susan T. Shero, Yuling Hong · 2019 · Circulation
  88. Management of ST-elevation myocardial infarction according to European and American guidelines
    Stephan Windecker, Rosa‐Ana Hernandez‐Antolín, Giulio Giuseppe Stefanini, William C. Wijns, José Luis Zamorano · 2014 · EuroIntervention
  89. Consensus recommendations for using the Multiplate® for platelet function monitoring before cardiac surgery
    Robert Sekun Kong, A. Trimmings, Nevil Hutchinson, Ranjodh S. Gill, Seema Agarwal, Simon J. Davidson, Marco Arcari · 2014 · International Journal of Laboratory Hematology
  90. Association of Admission Hemoglobin Levels and Acute Kidney Injury Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention
    Yacov Shacham, Amir Gal‐Oz, Eran Leshem‐Rubinow, Yaron Arbel, Nir Flint, Gad Keren, Arie Roth, Arie Steinvil · 2014 · Canadian Journal of Cardiology
  91. Rule-In and Rule-Out of Myocardial Infarction Using Cardiac Troponin and Glycemic Biomarkers in Patients with Symptoms Suggestive of Acute Coronary Syndrome
    Colleen R. Shortt, Jinhui Ma, Natasha Clayton, Jonathan Sherbino, Richard Paul Whitlock, Guillaume Paré, Stephen Hill, Matthew McQueen, Shamir R. Mehta, Philip James Devereaux et al. · 2016 · Clinical Chemistry
  92. Beta-blockers for suspected or diagnosed acute myocardial infarction
    Sanam Safi, Naqash J Sethi, Emil Eik Nielsen, Joshua Buron Feinberg, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2019 · Cochrane Database of Systematic Reviews
  93. Beta-Adrenergic Blockade in Critical Illness
    Rebecca Bruning, Hannah Dykes, Timothy W. Jones, Nathaniel B. Wayne, Andrea N. Sikora · 2021 · Frontiers in Pharmacology
  94. Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients
    Alexander W. Thomas, Sean van Diepen, Rachel B. Beekman, Shashank S. Sinha, Samuel B. Brusca, Carlos L. Alviar, Jacob Colin Jentzer, Erin Ann Bohula, Jason Neil Katz, Andi Shahu et al. · 2022 · JACC Advances
  95. Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies—a review
    Lauranne Scheldeman, Peter Sinnaeve, Gregory W. Albers, Robin Lemmens, Frans Van de Werf · 2024 · European Heart Journal
  96. Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?
    Kurt Huber, Eric Bates, Marco Valgimigli, Lars C. Wallentin, Steen Dalby Kristensen, Jeffrey L. Anderson, José Luis López Sendón, Marco Tubaro U, Christopher Bull Granger, Christoph Bode et al. · 2014 · American Heart Journal
  97. Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction
    Vikram Palamalai, MaryAnn M Murakami, Fred S. Apple · 2013 · Clinical Biochemistry
  98. Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction
    Gérard Helft, Jean‐Louis Georges, Xavier Mouranche, Aurélie Loyeau, Christian M. Spaulding, Christophe Caussin, Hakim Benamer, Philippe Garot, B. Livarek, Emmanuel Teíger et al. · 2015 · International Journal of Cardiology
  99. Quality of inpatient care in public and private hospitals in Sri Lanka
    Ravindra Prasan Rannan-Eliya, Nilmini Wijemunige, Isurujith Kongala Liyanage, Shanti Dalpatadu, Sanil de Alwis, Sarasi Amarasinghe, Shivanthan Shanthikumar · 2015 · Health Policy and Planning
  100. Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention
    M. Yudi, D. J. Clark, O. Farouque, David S. Eccleston, N. Andrianopoulos, Sharon Duffy, Angela Brennan, J. Lefkovits, Jay Ramchand, T. Yip et al. · 2016 · Internal Medicine Journal